|
Transcripts
Presentations
-
Addressing Clinical
Needs Through Science, Sandra L. Kweder, M.D. FDA, Office of Drug
Evaluation IV (Posted 1/31/2001)
-
Closing the Gap in Health
Care, Agency for Healthcare Research and Quality (Posted 1/31/2001)
-
Complications with the Use of
Anticonvulsants in Pregnancy, Mark Yerby, M.D. M.P.H. (Posted
1/31/2001)
-
Effect of Asthma on Pregnancy,
Robert S. Zeiger, MD, PhD (Posted 1/31/2001)
-
Industry Experience: Design
& Conduct of a Pregnancy PK Study, Catherine Stika, MD Assistant
Professor, Obstetrics & Gynecology Northwestern University
Medical School (Posted 1/31/2001)
-
Interface of Clinical
Pharmacology & Drug Safety, Gideon Koren, MD (Posted 1/31/2001)
-
Labeling Products for Use in
Pregnancy: Moving Forward, Sandra L. Kweder, M.D. FDA, Office of
Drug Evaluation IV (Posted 1/31/2001)
-
Legal Aspects of Studying
Pregnant Women, Ellen Wright Clayton (Posted 1/31/2001)
-
Management of Chronic
Hypertension During Pregnancy, San Antonio Evidence-Based Center
(Posted 1/31/2001)
-
March of Dimes Mission,
Nancy Green (Posted 1/31/2001)
-
PhRMA Perspective on Clinical Pharmacology Research in Pregnant Women,
Maria Palmisano, MD Director, Clinical Pharmacology/Experimental
Medicine, Bristol-Myers Squibb (Posted 1/31/2001)
-
Physiologic Changes In
Pregnancy: Effect on Drug Disposition, Marilynn Frederiksen (Posted
1/31/2001)
-
Psychopharmacology during
Pregnancy Addressing Clinical Need through Science, Katherine L.
Wisner, M.D., M.S. Professor of Psychiatry and Reproductive Biology,
Case Western Reserve University (Posted 1/31/2001)
-
Research Recommendations
from the NICHD Workshop on the Need to Study Drugs During Pregnancy,
Raymond L. Woosley, MD, PhD, President, American Society for Clinical
Pharmacology and Therapeutics (Posted 1/31/2001)
Back to Top
Back to Presentations
FDA/Center for Drug Evaluation and Research
Last Updated: March 08, 2001
Originator: OTCOM/DLIS
HTML by PKS |